Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 7;13:872458. doi: 10.3389/fimmu.2022.872458

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Ng, Chiu, Chan, Lin, Chung, Chung and Ku

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

IFN-γ and CXCL10 are correlated with disease activity, whereas CXCL9 is associated with disease severity in vitiligo patients. (A) Disease activity: IFN-γ, CXCL9, CXCL10, and GzmB in active and stable vitiligo and healthy control. (B) ROC curve for disease activity in IFN-γ and CXCL10, negative data of CXCL9 and GzmB not shown. (C) Disease severity: IFN-γ, CXCL9, CXCL10, and GzmB in VES < 5 and VES > 5 vitiligo patients. (D) ROC curve for disease severity in CXCL9, negative data of IFN-γ, CXCL10 and GzmB not shown (*p < 0.05, **p < 0.01). Ns, non-significant.